Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2012

GlobalData, February 2012, Pages: 79

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2012" provides data on the Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Basal Cell Carcinoma (Basal Cell Epithelioma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Basal Cell Carcinoma (Basal Cell Epithelioma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Basal Cell Carcinoma (Basal Cell Epithelioma) , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Basal Cell Carcinoma (Basal Cell Epithelioma)
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Galderma S.A.
Clinical Trial Overview of Galderma S.A.
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Graceway Pharmaceuticals, LLC
Clinical Trial Overview of Graceway Pharmaceuticals, LLC
Peplin Inc.
Clinical Trial Overview of Peplin Inc.
MEDA Pharma GmbH & Co. KG
Clinical Trial Overview of MEDA Pharma GmbH & Co. KG
AB Science
Clinical Trial Overview of AB Science
Xoft Inc.
Clinical Trial Overview of Xoft Inc.
G&E Herbal Biotechnology Co., Ltd.
Clinical Trial Overview of G&E Herbal Biotechnology Co., Ltd.
TopoTarget A/S
Clinical Trial Overview of TopoTarget A/S
Meda AB
Clinical Trial Overview of Meda AB
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Norwegian University of Science and Technology
Clinical Trial Overview of Norwegian University of Science and Technology
Northwestern University
Clinical Trial Overview of Northwestern University
Shaheed Beheshti Medical University
Clinical Trial Overview of Shaheed Beheshti Medical University
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Maastricht University Medical Center
Clinical Trial Overview of Maastricht University Medical Center
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Rambam Health Care Campus
Clinical Trial Overview of Rambam Health Care Campus
Children's Hospital & Research Center Oakland
Clinical Trial Overview of Children's Hospital & Research Center Oakland
University of Ioannina
Clinical Trial Overview of University of Ioannina
Bispebjerg Hospital
Clinical Trial Overview of Bispebjerg Hospital
Ruhr University Bochum
Clinical Trial Overview of Ruhr University Bochum
The University of Nottingham
Clinical Trial Overview of The University of Nottingham
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Arizona Cancer Center
Clinical Trial Overview of Arizona Cancer Center
University Hospital Tubingen
Clinical Trial Overview of University Hospital Tubingen
University of Glasgow
Clinical Trial Overview of University of Glasgow
Queen's University
Clinical Trial Overview of Queen's University
Stanford University
Clinical Trial Overview of Stanford University
University of California, San Diego
Clinical Trial Overview of University of California, San Diego
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Five Key Clinical profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, North America, Top Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, G7 Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Graceway Pharmaceuticals, LLC, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Peplin Inc., 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MEDA Pharma GmbH & Co. KG, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by AB Science, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Xoft Inc., 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by G&E Herbal Biotechnology Co., Ltd., 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by TopoTarget A/S, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Meda AB, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaheed Beheshti Medical University, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital & Research Center Oakland, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ioannina, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bispebjerg Hospital, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ruhr University Bochum, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Nottingham, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Arizona Cancer Center, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Glasgow, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-

List of Figures
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, G7 Countries (%), 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Sickle Cell Disease Global Clinical Trials Review, H2, 2012
• Basal Cell Carcinoma Global Clinical Trials Review, Q4, 2010
• Renal Cell Carcinoma (Event Driven)
• Osteoporosis Global Clinical Trials Review, H2, 2012
• Bronchitis Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Atopic Dermatitis (Eczema) Global Clinical Trials Review, H1, 2012
• Other Metabolic Disorders Global Clinical Trials Review, H1, 2012
• Shock Global Clinical Trials Review, H2, 2012
• Asthma Global Clinical Trials Review, H1, 2012